The windows are opening. While most stock market candidates still had to watch the successful placements of Porsche AG, IONOS and thyssenkrupp nucera behind half-drawn curtains, the IPOs of SCHOTT Pharma and Renk seem to be the starting signal for a whole series of ventures. This is not only an important signal for the German capital market, which has been...
Matthias Jörss, Chief Economist at SALytic Invest, talks to Carsten Werle and Marcus Sander about his view of the capital markets, the right conclusions for issuers and why he is open-minded about paid research. (German version) [audio mp3="https://www.allincapitals.de/wp-content/uploads/2022/10/TheVoiceOfFFM-0004.mp3"][/audio]...
There has long been a lively discussion in the financial world about whether asset valuation should be regarded more as a quantitatively exact science or rather as an "artistic" discipline. To many company representatives, this discussion may seem quite academic in the current situation. After all, the stock market correction of the current year has hit the share prices and...